γ-Aminobutyric Acid as a Promoting Factor of Cancer Metastasis; Induction of Matrix Metalloproteinase Production Is Potentially Its Underlying Mechanism

Cancer Research

Volumn 63, Issue 23, 2003, Pages 8090-8096

  Azuma, Haruhito ^a   Inamoto, Teruo ^b   Sakamoto, Takeshi ^a   Kiyama, Satoshi ^a   Ubai, Takanobu ^a   Shinohara, Yuko ^a   Maemura, Kentaro ^a   Tsuji, Motomu ^a   Segawa, Naoki ^c   Masuda, Hiroshi ^d   Takahara, Kiyoshi ^e   Katsuoka, Yoji ^a   Watanabe, Masahito ^a  

^a OSAKA MEDICAL COLLEGE   (Japan)

^b Saiseikai Ibaraki Hospital   (Japan)

^c SHIZUOKA SAISEIKAI GENERAL HOSPITAL   (Japan)

^d Hirakata City Hospital   (Japan)

^e OTSU RED CROSS HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

3 AMINOPROPYL(DIETHOXYMETHYL)PHOSPHINIC ACID; 4 AMINOBUTYRIC ACID; 4 AMINOBUTYRIC ACID A RECEPTOR; 4 AMINOBUTYRIC ACID B RECEPTOR; 4 AMINOBUTYRIC ACID B RECEPTOR BLOCKING AGENT; 4 AMINOBUTYRIC ACID B RECEPTOR STIMULATING AGENT; BACLOFEN; ILOMASTAT; MATRIGEL; MATRIX METALLOPROTEINASE; MATRIX METALLOPROTEINASE INHIBITOR;

ADULT; AGED; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL; CANCER CELL CULTURE; CELL ASSAY; CELL INVASION; CONTROLLED STUDY; DRUG MECHANISM; ENZYME SYNTHESIS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; METASTASIS; MOLECULAR MECHANICS; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE HYPERTROPHY; PROTEIN EXPRESSION; PROTEIN FUNCTION;

AGED; AGED, 80 AND OVER; BACLOFEN; DIPEPTIDES; ENZYME INDUCTION; GABA AGONISTS; GAMMA-AMINOBUTYRIC ACID; GLUTAMATE DECARBOXYLASE; HUMANS; IMMUNOHISTOCHEMISTRY; ISOENZYMES; LYMPHATIC METASTASIS; MALE; MATRIX METALLOPROTEINASES; MIDDLE AGED; NEOPLASM METASTASIS; PROSTATIC HYPERPLASIA; PROSTATIC NEOPLASMS; PROTEASE INHIBITORS; RECEPTORS, GABA-B; RISK FACTORS;

EID: 10744224102     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Chodak, G. W., Thisted, R. A., Gerber, G. S., Johansson, J. E., Adolfsson, J., Jones, G. W., Chisholm, G. D., Moskovitz, B., Livne, P. M., and Warner, J. Results of conservative management of clinically localized prostate cancer. N. Engl. J. Med., 330: 242-248, 1994.
2. Helgesen, F., Holmberg, L., Johansson, J. E., Bergstrom, R., and Adami, H. O. Trends in prostate cancer survival in Sweden, 1960 through 1988: evidence of increasing diagnosis of nonlethal tumors. J. Natl. Cancer Inst. (Bethesda), 88: 1216-1221, 1996.
3. Bennett, C. L., Tosteson, T. D., Schmitt, B., Weinberg, P. D., Ernstoff, M. S., and Ross, S. D. Maximum androgen-blockade with medical or surgical castration in advanced prostate cancer: a meta-analysis of nine published randomized controlled trials and 4128 patients using flutamide. Prostate Cancer Prostatic Dis., 2: 4-8, 1999.
4. Watanabe, M., Maemura, K., Kanbara, K., Tamayama, T., and Hayasaki, H. GABA and GABA receptors in the central nervous system and other organs. Int. Rev. Cytol., 213: 1-47, 2002.
5. Roberts, E. Adventures with GABA: fifty years on. In: D. L. Martin and R. W. Olsen (eds.), GABA in the Nervous System: The View at Fifty Years, pp. 1-24. Philadelphia: Lippincott Williams and Wilkins, 2000.
6. Gilon, P., Remacle, C., de Varebeke, J., Pauwels, G., and Hoet, J. J. GABA content and localisation of high-affinity GABA uptake during the development of the rat pancreas. Cell. Mol. Biol., 33: 573-585, 1987.
7. Tamayama, T., Kanbara, K., Maemura, K., Kuno, M., and Watanabe, M. Localization of GABA, GAD65 and GAD67 in rat epiphyseal growth plate chondrocytes. Acta Histochem. Cytochem., 34: 201-206, 2001.
8. Maemura, K., Yamauchi, H., Hayasaki, H., Kanbara, K., Tamayama, T., Hirata, I., and Watanabe, M. γ-Amino-butyric acid immunoreactivity in intramucosal colonic tumors. J. Gastroenterol. Hepatol., 18: 1089-1094, 2003.
9. Kleinrok, Z., Matuszek, M., Jesipowicz, J., Matuszek, B., Opolski, A., and Radzikowski, C. GABA content and GAD activity in colon tumors taken from patients with colon cancer or from xenografted human colon cancer cells growing as s.c. tumors in athymic nu/nu mice. J. Physiol. Pharmacol., 49: 303-310, 1998.
10. Matuszek, M., Jesipowicz, M., and Kleinrok, Z. GABA content and GAD activity in gastric cancer. Int. Med. J. Exp. Clin. Res., 7: 377-381, 2001.
11. McCawley, L. J., and Matrisian, L. M. Matrix metalloproteinases: multifunctional contributors to tumor progression. Mol. Med. Today, 6: 149-156, 2000.
12. Sternlicht, M. D., and Werb, Z. How matrix metalloproteinases regulate cell behavior. Annu. Rev. Cell Dev. Biol., 17: 463-516, 2001.
13. Egeblad, M., and Werb, Z. New functions for the matrix metalloproteinases in cancer progression. Nat. Rev. Cancer, 2: 161-174, 2002.
14. Gleason, D. F., and Mellinger, G. T. Prediction of prognosis for prostatic adenocarcinoma by combined histological grading and clinical staging. J. Urol., 111: 58-64, 1974.
15. Imai, K., Hiramatsu, A., Fukushima, D., Pierschbacher, M. D., and Okada, Y. Degradation of decorin by matrix metalloproteinases: identification of the cleavage sites, kinetic analyses and transforming growth factor-β1 release. Biochem. J., 322: 809-814, 1997.
16. Giannelli, G., Falk-Marzillier, J., Schiraldi, O., Stetler-Stevenson, W. G., and Quaranta, V. Induction of cell migration by matrix metalloprotease-2 cleavage of laminin-5. Science (Wash. DC), 277: 225-228, 1997.
17. Birchmeier, W. E-cadherin as a tumor (invasion) suppressor gene. Bioessays, 17: 97-99, 1995.
18. Lochter, A., Galosy, S., Muschler, J., Freedman, N., Werb, Z., and Bissell, M. J. Matrix metalloproteinase stromelysin-1 triggers a cascade of molecular alterations that leads to stable epithelial-to-mesenchymal conversion and a premalignant phenotype in mammary epithelial cells. J. Cell Biol., 139: 1861-1872, 1997.
19. Joseph, J., Niggemann, B., Zaenker, K. S., and Entschladen, F. The neurotransmitter γ-aminobutyric acid is an inhibitory regulator for the migration of SW 480 colon carcinoma cells. Cancer Res., 62: 6467-6469, 2002.
20. Coussens, L. M., Fingleton, B., and Matrisian, L. M. Matrix metalloproteinase inhibitors and cancer: trials and tribulations. Science (Wash. DC). 295: 2387-2392, 2002.